BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3227914)

  • 21. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylene blue attenuates vasodilation and enhances vasoconstriction in response to endothelin-1 in the pig nasal mucosa.
    Auberson S; Lacroix JS; Morel DR; Lehmann W; Lundberg JM
    Acta Physiol Scand; 1991 Jun; 142(2):149-56. PubMed ID: 1715110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.
    Malmström RE; Modin A; Lundberg JM
    Eur J Pharmacol; 1996 Jun; 305(1-3):145-54. PubMed ID: 8813545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenergic and non-adrenergic vasoconstrictor mechanisms in the human nasal mucosa.
    Fischer L; Auberson S; Bretton C; Lacroix JS
    Rhinology; 1993 Mar; 31(1):11-5. PubMed ID: 8100640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prejunctional regulation of reserpine-resistant sympathetic vasoconstriction and release of neuropeptide Y in the pig.
    Modin A; Pernow J; Lundberg JM
    J Auton Nerv Syst; 1996 Feb; 57(1-2):13-21. PubMed ID: 8867080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the acute influence of neuropeptide Y and sympathetic stimulation on the composition of blood cells in the splenic vein in vivo.
    Modin A; Pernow J; Lundberg JM
    Regul Pept; 1993 Sep; 47(2):159-69. PubMed ID: 8234902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs.
    Revington M; Lacroix JS; Potter EK
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):823-31. PubMed ID: 9457655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the neuropeptide YY1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo .
    Malmström RE; Lundberg JM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):633-42. PubMed ID: 8938663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
    Lacroix JS; Ulman LG; Potter EK
    Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic and parasympathetic interaction in vascular control of the nasal mucosa in anaesthetized cats.
    Lacroix JS; Ulman LG; Potter EK
    J Physiol; 1994 Oct; 480 ( Pt 2)(Pt 2):325-31. PubMed ID: 7869247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y (NPY) and sympathetic control of blood flow in oral mucosa and dental pulp in the cat.
    Edwall B; Gazelius B; Fazekas A; Theodorsson-Norheim E; Lundberg JM
    Acta Physiol Scand; 1985 Oct; 125(2):253-64. PubMed ID: 2866663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J; Modin A; Lundberg JM
    Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Theodorsson-Norheim E; Hamberger B
    Neurosci Lett; 1986 Jan; 63(1):96-100. PubMed ID: 3005926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y may mediate effects of sympathetic nerve stimulations on colonic motility and blood flow in the cat.
    Hellström PM; Olerup O; Tatemoto K
    Acta Physiol Scand; 1985 Aug; 124(4):613-24. PubMed ID: 2864782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine.
    Modin A; Pernow J; Lundberg JM
    J Auton Nerv Syst; 1994 Oct; 49(2):123-34. PubMed ID: 7806765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
    Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
    J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
    Vonend O; Okonek A; Stegbauer J; Habbel S; Quack I; Rump LC
    Cardiovasc Res; 2005 May; 66(2):345-52. PubMed ID: 15820203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
    Franco-Cereceda A; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.